Bill & Melinda Gates Foundation

Latest statistics and disclosures from Bill & Melinda Gates Foundation's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are CVAC, Lumiradx, BNTX, VIR, IMCR, and represent 90.40% of Bill & Melinda Gates Foundation's stock portfolio.
  • Added to shares of these 2 stocks: Lumiradx (+$46M), Sera Prognostics Inc-a (+$8.7M).
  • Started 2 new stock positions in Sera Prognostics Inc-a, Lumiradx.
  • Reduced shares in these 2 stocks: BNTX (-$243M), VIR (-$91M).
  • Bill & Melinda Gates Foundation was a net seller of stock by $-280M.
  • Bill & Melinda Gates Foundation has $342M in assets under management (AUM), dropping by -47.51%.
  • Central Index Key (CIK): 0001663801

Tip: Access up to 7 years of quarterly data

Positions held by Bill & Melinda Gates Foundation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Bill & Melinda Gates Foundation

Companies in the Bill & Melinda Gates Foundation portfolio as of the September 2021 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Curevac N V (CVAC) 50.1 $171M 3.1M 54.61
Lumiradx SHS 13.5 $46M NEW 5.6M 8.27
Biontech Se Sponsored Ads (BNTX) 11.9 $41M -85% 149k 273.08
Vir Biotechnology (VIR) 8.6 $30M -75% 678k 43.52
Immuncore Hldgs Ads (IMCR) 6.3 $21M 577k 37.09
Butterfly Network Cl A Com (BFLY) 3.1 $11M 1.0M 10.48
Sera Prognostics Cl A Com 2.5 $8.7M NEW 780k 11.16
Atreca Cl A Com (BCEL) 2.5 $8.7M 1.4M 6.23
Amyris Com New (AMRS) 1.2 $4.0M 292k 13.68
Zymergen (ZY) 0.2 $800k 60k 13.34

Past Filings by Bill & Melinda Gates Foundation

SEC 13F filings are viewable for Bill & Melinda Gates Foundation going back to 2020